Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Pulmonary Radiofrequency Ablation - An International Study Survey

KARIN STEINKE, PATRICK E. SEWELL, DAMIEN DUPUY, RICCARDO LENCIONI, THOMAS HELMBERGER, STEPHEN T. KEE, AUGUSTINUS L. JACOB, DEREK W. GLENN, JULIE KING and DAVID L. MORRIS
Anticancer Research January 2004, 24 (1) 339-344;
KARIN STEINKE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PATRICK E. SEWELL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAMIEN DUPUY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RICCARDO LENCIONI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THOMAS HELMBERGER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHEN T. KEE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AUGUSTINUS L. JACOB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DEREK W. GLENN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JULIE KING
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID L. MORRIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: The lung is the most common site for primary cancer worldwide as well as being a common site of metastases for various malignancies. Percutaneous radiofrequency ablation (RFA) is rapidly evolving as a new minimally invasive tool for the treatment of pulmonary tumors. Patients and Methods: A questionnaire was sent by e-mail to 14 centres around the world, which we knew or thought were performing percutaneous pulmonary RFA, to retrospectively survey their experience in this field including the number of ablations done to date, indications, method, peri- and postprocedural complications. Results: Seven centers reported 493 percutaneous procedures in lung tumors. Two deaths have been reported. Complications were subdivided into major and minor complications. Pneumothorax occurred in up to 30% of interventions with less than 10% requiring intercostal drainage. Pleural effusion requiring aspiration occurred in less than 10% of cases. Conclusion: With almost 500 procedures done to date, percutaneous pulmonary RFA appears to be a safe, minimally invasive tool for local pulmonary tumor control with negligible mortality, little morbidity, short hospital stay and gain in quality of life.

  • Received June 10, 2003.
  • Accepted December 19, 2003.
  • Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 24 (1)
Anticancer Research
Vol. 24, Issue 1
January-February 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pulmonary Radiofrequency Ablation - An International Study Survey
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Pulmonary Radiofrequency Ablation - An International Study Survey
KARIN STEINKE, PATRICK E. SEWELL, DAMIEN DUPUY, RICCARDO LENCIONI, THOMAS HELMBERGER, STEPHEN T. KEE, AUGUSTINUS L. JACOB, DEREK W. GLENN, JULIE KING, DAVID L. MORRIS
Anticancer Research Jan 2004, 24 (1) 339-344;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Pulmonary Radiofrequency Ablation - An International Study Survey
KARIN STEINKE, PATRICK E. SEWELL, DAMIEN DUPUY, RICCARDO LENCIONI, THOMAS HELMBERGER, STEPHEN T. KEE, AUGUSTINUS L. JACOB, DEREK W. GLENN, JULIE KING, DAVID L. MORRIS
Anticancer Research Jan 2004, 24 (1) 339-344;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer
  • 18F-FDG PET/CT for the Prediction and Detection of Local Recurrence After Radiofrequency Ablation of Malignant Lung Lesions
  • Metastatic Bone Disease: Diagnosis, Evaluation, and Treatment
  • Complications after lung radiofrequency ablation: risk factors for lung inflammation
  • Google Scholar

More in this TOC Section

  • Four Different Artificial Intelligence Models Versus Logistic Regression to Enhance the Diagnostic Accuracy of Fecal Immunochemical Test in the Detection of Colorectal Carcinoma in a Screening Setting
  • In-hospital Outcomes Between Total Parenteral Nutrition and Enteral Feeding in Esophageal and Gastric Cancer: A Nationwide Analysis
  • Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire